Medtech Insight is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By


QUOTED. 7 October 2019. Doug Stearn.

Executive Summary

Once upon a time, the US FDA's largest challenge around recalls communication was getting the word out about potentially dangerous products. But now a bigger risk is that recall notifications will be missed in a daily flood of communications, the agency's Doug Stearn says. Check out his comment here.

“People overlook [recalls] information because there’s too much of it.” – Doug Stearn, deputy director for regulatory affairs, US FDA’s Center for Food Safety and Applied Nutrition

Click here for a free trial of Medtech Insight


Related Content





Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts